In one recent study, it was found that the use of antibodies against SP induces cell death in several cancer cell types and that this effect is accompanied by a decrease in signaling through the MAPK pathway and a decrease in the basal activity and expression of Her2 and EGFR [42]. This evidence concerns the gene ERBB2 and cancer.